Clinical trial
Post-Market Clinical Follow-up Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMS
NCT02588430 is registered in ClinicalTrials.gov with Retina Implant AG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post-Market Clinical Follow-up Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMS
- Lead sponsor
- Retina Implant AG
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- March 31, 2019
- Completion date
- June 30, 2030
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.